News
FDA approves flurry of drugs ahead of holiday season
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
News
AZ gets EU okay for Tagrisso in early-stage lung cancer
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in the class to be approved in the EU for a form of early-stage lung cancer.
News
PBM reform dropped in Congress' funding package
Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
News
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome.
News
Lilly grabs first-ever FDA nod for a sleep apnoea drug
Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
